Supreme $FIRE Crosses Revenue Milestone

SupremePharmaceuticalsLogo(TSX.V: FIRE)

Supreme Pharmaceuticals Inc. is pleased to announce that 7ACRES’ first month of sales exceeded $1,500,000, and that such sales will be recorded in the quarter ended September 30, 2017.

“Our first sales represent a significant milestone for Supreme and demonstrate our ability to cultivate premium cannabis, navigate the regulatory process, and deliver commercial quantities of a high-quality product to our retail partners. Our first sales offer additional validation of our ability to execute on our unique, scalable and focused business model”.

-John Fowler, CEO of Supreme.

As the leading business-to-business (“B2B”) focused Licensed Producer in Canada, Supreme is working toward establishing a standard for B2B cannabis transactions. Due to the rigorous regulatory oversight of legal cannabis markets, large commercial B2B transactions require intensive due diligence. Supreme requires active and potential clients to participate in an industry-leading B2B due diligence process including chemical analysis, pesticide testing, physical inspection and a thorough inspection of the 7ACRES Hybrid Facility.